Unresectable Penile Squamous Cell Carcinoma
1 clinical trials · Condition
◉ Watch Unresectable Penile Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis (NCT06104618) | Mayo Clinic | 2023-12-21 |
Track Unresectable Penile Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.